ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic Therapeutics with $75 Million in Series A Funding
/PRNewswire/ -- ATP, a leader in life sciences venture capital, today debuted Intergalactic Therapeutics, a non-viral gene therapy platform led by a top...
Source: prnewswire.com